NEW YORK (GenomeWeb News) - Arizona's Translational Genomics Research Institute plans to boost its workforce in the coming year, maintaining the double-digit pace of growth it highlighted in a recent economic impact study.

"It will be about 80 percent research investigation, about evenly divided between computational biology and wet labs, with really only about a fifth of the positions coming in the area of administrative project management," Jeffrey Trent, TGen's president and research director, told GenomeWeb Daily News earlier this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.